BioNano Genomics Inc vs Invesco WilderHill Clean Energy ETF — how do they compare? BioNano Genomics Inc trades at $1.17 (market cap $13.20M), while Invesco WilderHill Clean Energy ETF trades at $34.82. The key difference: Invesco WilderHill Clean Energy ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | PBW | |
|---|---|---|
Market Cap | $13.20M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.92 | $46.99 |
52-Week Low | $1.09 | $22.23 |
Enterprise Value | $15.81M | — |
Signals from Pluang's Aura AI — not financial advice
Bionano Genomics (BNGO) trades at $1.17, down 2.5% today, but maintains a bullish technical signal with strong moving average support. The company shows improving fundamentals with revenue stabilizing around $29M annually and narrowing losses, though it remains unprofitable with a -109.95% net margin. Recent positive developments include debt retirement and growing adoption of optical genome mapping technology.
BNGO presents a high-risk, high-reward opportunity with analyst consensus leaning bullish (57% buy ratings). The stock trades at attractive valuation multiples (P/S 0.31, P/B 0.36) but faces execution risks in achieving profitability. Key catalysts include continued technology adoption and potential margin improvement, while persistent losses and competitive pressures remain concerns.
PBW (Invesco WilderHill Clean Energy ETF) trades at $34.00, down 3.46% with a bearish technical signal from moving averages. The ETF shows oversold conditions with RSI readings below 30, while clean energy sector news highlights both volatility and growth potential driven by energy security concerns and data center demand. Recent articles note PBW's 34% year-to-date gains but caution about rate cycle sensitivity.
Outlook remains mixed with technical weakness offset by clean energy tailwinds. Investment opportunity lies in global energy transition trends, but risks include interest rate sensitivity and sector volatility. The ETF's performance is heavily influenced by macroeconomic factors rather than individual company fundamentals.
Trailing returns across standard periods
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →